Bomedemstat
- Generic Name
- Bomedemstat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H34FN7O2
- CAS Number
- 1990504-34-1
- Unique Ingredient Identifier
- Y2T4ALDEAT
- Associated Conditions
- -
- Associated Therapies
- -
Bomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-05-02
- Last Posted Date
- 2024-01-10
- Target Recruit Count
- 90
- Registration Number
- NCT03136185
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇮🇹Azienda Ospedaliero Universitaria Careggi, Florence, Italy
🇩🇪Universitatsklinikum Essen, Essen, Germany
A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-07-25
- Last Posted Date
- 2023-07-11
- Target Recruit Count
- 45
- Registration Number
- NCT02842827
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath